Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
BABY's Cash to Debt is ranked higher than
88% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. BABY: No Debt )
BABY' s 10-Year Cash to Debt Range
Min: 0.32   Max: No Debt
Current: No Debt

Equity to Asset 0.81
BABY's Equity to Asset is ranked higher than
84% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. BABY: 0.81 )
BABY' s 10-Year Equity to Asset Range
Min: -1.71   Max: 0.94
Current: 0.81

-1.71
0.94
Interest Coverage No Debt
BABY's Interest Coverage is ranked higher than
92% of the 271 Companies
in the Global Medical Devices industry.

( Industry Median: 365.56 vs. BABY: No Debt )
BABY' s 10-Year Interest Coverage Range
Min: 4.92   Max: 9999.99
Current: No Debt

4.92
9999.99
F-Score: 7
Z-Score: 11.24
M-Score: -2.53
WACC vs ROIC
5.71%
11.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.89
BABY's Operating margin (%) is ranked higher than
88% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 4.63 vs. BABY: 12.89 )
BABY' s 10-Year Operating margin (%) Range
Min: -32.53   Max: 15.75
Current: 12.89

-32.53
15.75
Net-margin (%) 9.13
BABY's Net-margin (%) is ranked higher than
86% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. BABY: 9.13 )
BABY' s 10-Year Net-margin (%) Range
Min: -27.59   Max: 14.29
Current: 9.13

-27.59
14.29
ROE (%) 9.88
BABY's ROE (%) is ranked higher than
84% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. BABY: 9.88 )
BABY' s 10-Year ROE (%) Range
Min: -18.17   Max: 10.21
Current: 9.88

-18.17
10.21
ROA (%) 7.63
BABY's ROA (%) is ranked higher than
88% of the 513 Companies
in the Global Medical Devices industry.

( Industry Median: 0.75 vs. BABY: 7.63 )
BABY' s 10-Year ROA (%) Range
Min: -11.99   Max: 9
Current: 7.63

-11.99
9
ROC (Joel Greenblatt) (%) 47.61
BABY's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 5.44 vs. BABY: 47.61 )
BABY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -130.1   Max: 72.5
Current: 47.61

-130.1
72.5
Revenue Growth (3Y)(%) 10.30
BABY's Revenue Growth (3Y)(%) is ranked higher than
86% of the 343 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. BABY: 10.30 )
BABY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -61.8   Max: 38.3
Current: 10.3

-61.8
38.3
» BABY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

BABY Guru Trades in Q1 2014

Chuck Royce 2,100 sh (New)
Joel Greenblatt 596,487 sh (+902.40%)
Paul Tudor Jones 26,776 sh (+47.94%)
Steven Cohen Sold Out
Diamond Hill Capital 968,350 sh (-0.51%)
Jim Simons 167,945 sh (-2.51%)
» More
Q2 2014

BABY Guru Trades in Q2 2014

Jim Simons 405,145 sh (+141.24%)
Diamond Hill Capital 969,630 sh (+0.13%)
Chuck Royce Sold Out
Joel Greenblatt 595,883 sh (-0.10%)
Paul Tudor Jones 24,823 sh (-7.29%)
» More
Q3 2014

BABY Guru Trades in Q3 2014

Ken Fisher 548,495 sh (New)
Paul Tudor Jones 25,620 sh (+3.21%)
Diamond Hill Capital 960,470 sh (-0.94%)
Joel Greenblatt 400,972 sh (-32.71%)
Jim Simons 269,045 sh (-33.59%)
» More
Q4 2014

BABY Guru Trades in Q4 2014

Joel Greenblatt 499,207 sh (+24.50%)
Ken Fisher 585,730 sh (+6.79%)
Jim Simons Sold Out
Diamond Hill Capital 935,868 sh (-2.56%)
Paul Tudor Jones 22,143 sh (-13.57%)
» More
» Details

Insider Trades

Latest Guru Trades with BABY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.30
BABY's P/E(ttm) is ranked higher than
80% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 39.30 )
BABY' s 10-Year P/E(ttm) Range
Min: 11.47   Max: 723.45
Current: 39.3

11.47
723.45
Forward P/E 27.17
BABY's Forward P/E is ranked higher than
78% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 27.17 )
N/A
PE(NRI) 39.90
BABY's PE(NRI) is ranked higher than
84% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 39.90 )
BABY' s 10-Year PE(NRI) Range
Min: 11.43   Max: 699.33
Current: 39.9

11.43
699.33
P/B 3.70
BABY's P/B is ranked higher than
66% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. BABY: 3.70 )
BABY' s 10-Year P/B Range
Min: 0.79   Max: 5.69
Current: 3.7

0.79
5.69
P/S 3.58
BABY's P/S is ranked higher than
59% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 4.29 vs. BABY: 3.58 )
BABY' s 10-Year P/S Range
Min: 0.95   Max: 8.5
Current: 3.58

0.95
8.5
PFCF 35.40
BABY's PFCF is ranked higher than
82% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 35.40 )
BABY' s 10-Year PFCF Range
Min: 12.65   Max: 556
Current: 35.4

12.65
556
POCF 30.60
BABY's POCF is ranked higher than
81% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 30.60 )
BABY' s 10-Year POCF Range
Min: 10.17   Max: 740
Current: 30.6

10.17
740
EV-to-EBIT 26.68
BABY's EV-to-EBIT is ranked higher than
84% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 26.68 )
BABY' s 10-Year EV-to-EBIT Range
Min: -2754.6   Max: 409.7
Current: 26.68

-2754.6
409.7
Shiller P/E 101.00
BABY's Shiller P/E is ranked higher than
78% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 101.00 )
BABY' s 10-Year Shiller P/E Range
Min: 19.55   Max: 2156
Current: 101

19.55
2156
Current Ratio 3.15
BABY's Current Ratio is ranked higher than
74% of the 502 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. BABY: 3.15 )
BABY' s 10-Year Current Ratio Range
Min: 1.41   Max: 16.01
Current: 3.15

1.41
16.01
Quick Ratio 2.57
BABY's Quick Ratio is ranked higher than
75% of the 502 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. BABY: 2.57 )
BABY' s 10-Year Quick Ratio Range
Min: 1   Max: 15.09
Current: 2.57

1
15.09
Days Inventory 97.38
BABY's Days Inventory is ranked higher than
87% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 174.47 vs. BABY: 97.38 )
BABY' s 10-Year Days Inventory Range
Min: 82.54   Max: 135.33
Current: 97.38

82.54
135.33
Days Sales Outstanding 84.40
BABY's Days Sales Outstanding is ranked higher than
70% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 82.87 vs. BABY: 84.40 )
BABY' s 10-Year Days Sales Outstanding Range
Min: 65.2   Max: 112.34
Current: 84.4

65.2
112.34

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 19.30
BABY's Price/Net Current Asset Value is ranked higher than
72% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 19.30 )
BABY' s 10-Year Price/Net Current Asset Value Range
Min: 1.26   Max: 12.4
Current: 19.3

1.26
12.4
Price/Tangible Book 7.80
BABY's Price/Tangible Book is ranked higher than
61% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 8.30 vs. BABY: 7.80 )
BABY' s 10-Year Price/Tangible Book Range
Min: 1.02   Max: 64.5
Current: 7.8

1.02
64.5
Price/DCF (Projected) 2.30
BABY's Price/DCF (Projected) is ranked higher than
86% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 2.30 )
BABY' s 10-Year Price/DCF (Projected) Range
Min: 0.81   Max: 5.56
Current: 2.3

0.81
5.56
Price/Median PS Value 1.40
BABY's Price/Median PS Value is ranked higher than
64% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. BABY: 1.40 )
BABY' s 10-Year Price/Median PS Value Range
Min: 0.16   Max: 2.79
Current: 1.4

0.16
2.79
Price/Peter Lynch Fair Value 11.90
BABY's Price/Peter Lynch Fair Value is ranked higher than
92% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 11.90 )
BABY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.76   Max: 1.68
Current: 11.9

0.76
1.68
Price/Graham Number 3.70
BABY's Price/Graham Number is ranked higher than
80% of the 575 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. BABY: 3.70 )
BABY' s 10-Year Price/Graham Number Range
Min: 1.76   Max: 10.99
Current: 3.7

1.76
10.99
Earnings Yield (Greenblatt) 3.70
BABY's Earnings Yield (Greenblatt) is ranked higher than
80% of the 493 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. BABY: 3.70 )
BABY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 17.5
Current: 3.7

0.2
17.5
Forward Rate of Return (Yacktman) 9.73
BABY's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. BABY: 9.73 )
BABY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.5   Max: 75
Current: 9.73

-1.5
75

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:NM4.Germany,
Natus Medical, Inc., was incorporated in California in May 1987 and reincorporated in Delaware in August 2000. The Company is a provider of newborn care and neurology healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company offers two product families: Neurology and Newborn Care. Neurology includes products for diagnostic electroencephalography (EEG), electromyography (EMG), diagnostic sleep analysis or polysomnography (PSG), intra-operative monitoring (IOM), and transcranial doppler ultrasound technology. Newborn Care includes products for newborn care including hearing screening, brain injury, thermoregulation, jaundice management, and various disposable products, as well as products for diagnostic hearing assessment for children through adult populations, and products to diagnose and assist in treating balance and mobility disorders. The Company is subject to inspection and market surveillance by the FDA to determine compliance with regulatory requirements.
» More Articles for NAS:BABY

Headlines

Articles On GuruFocus.com
Diamond Hill Small Cap Fund Q4 2014 Commentary Mar 17 2015 
Diamond Hill Small Cap Fund Third Quarter Letter Oct 26 2014 
Diamond Hill Capital Comments on Natus Medical Inc Oct 17 2014 
Diamond Hill Small Cap Fund Third Quarter 2014 Commentary Oct 17 2014 
Diamond Hill Capital Comments on Natus Medical Inc Jun 26 2014 
Diamond Hill Small Cap Fund Commentary – First Quarter 2014 Jun 25 2014 
Weekly CEO Sells Highlight: OCZ Technology Group Inc, Workday Inc, Gilead Sciences Inc, Natus Medica Dec 09 2013 
Natus Medical Inc. Reports Operating Results (10-Q) Nov 05 2010 
David Nierenberg’s Top Holdings: MOVE, ESIO, BABY, RSYS, HPY, SPN Aug 27 2010 
Natus Medical Inc. (BABY) VP Finance and CFO Steven J Murphy sells 1,814 Shares Aug 19 2010 


More From Other Websites
Natus Medical to Hold 2015 First Quarter Financial Results Conference Call on April 22nd Apr 08 2015
Natus Medical to Hold 2015 First Quarter Financial Results Conference Call on April 22nd Apr 08 2015
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic... Mar 27 2015
The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest... Mar 23 2015
NATUS MEDICAL INC Financials Mar 21 2015
International Day of Happiness: Stocks to Make You Smile - Analyst Blog Mar 20 2015
NATUS MEDICAL INC Files SEC form 10-K, Annual Report Mar 16 2015
Natus Medical Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into... Mar 04 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Natus Medical... Mar 03 2015
Natus to Present at 27th Annual Roth Conference Feb 27 2015
Natus to Present at 27th Annual Roth Conference Feb 23 2015
Natus to Present at Raymond James 36th Annual Institutional Investors Conference Feb 16 2015
Natus to Present at Raymond James 36th Annual Institutional Investors Conference Feb 16 2015
Natus Medical (BABY) Beats Q4 Earnings, Revenues in Line - Analyst Blog Jan 29 2015
Natus Medical Inc Earnings Call scheduled for 11:00 am ET today Jan 28 2015
Natus Medical beats 4Q profit forecasts Jan 28 2015
Natus Medical beats 4Q profit forecasts Jan 28 2015
Q4 2014 Natus Medical Inc Earnings Release - Before Market Open Jan 28 2015
NATUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 28 2015
Natus Medical Announces Record Fourth Quarter and Full Year 2014 Financial Results Jan 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK